The Remote Catheter Manipulation Device Market is expected to grow at a 6.8% CAGR during the forecast period for 2024-2031.
Key Industry Insights & Findings from the Report:
- The increasing cases of cardiovascular conditions such as arrhythmias, coronary artery disease, and heart failure necessitate advanced catheterization procedures, boosting the demand for remote catheter manipulation devices.
- Minimally invasive techniques are becoming increasingly preferred over traditional open surgeries due to their benefits, such as lower risk of complications, reduced recovery time, and shorter hospital stays.
- North America dominated the market and accounted for a global revenue share in 2023.
- Inconsistent or inadequate reimbursement policies for procedures involving remote catheter manipulation devices can deter healthcare providers from adopting these technologies.
Radiation exposure is a serious concern during fluoroscopic procedures like electrophysiology (EP) studies and radiofrequency catheter ablation of arrhythmias. Ablation is a definitive treatment in many patients compared to antiarrhythmic drugs. Ablation procedures require mobile catheters inside the cardiac chambers and vascular system to recognize the arrhythmia substrate prior to ablation. Proper catheter manipulation requires a skilled electrophysiologist working under fluoroscopic guidance. This may result in significant X-ray exposure, which is a risk for both patients and medical staff. Operators typically don lead aprons to protect themselves from radiation, but wearing lead can result in greater fatigue and orthopedic injury during long procedures. To overcome this problem, robotic catheter systems, controlled mechanically are introduced in the market.
Products in the market include Niobe, VDrive, Sensei X, Amigo RCS, etc. Vdrive system consists of V-Sono ICE catheter manipulator and V-Loop variable loop catheter manipulator. Amigo was approved by the FDA for use in diagnostic EP studies of the right atrium and ventricle in 2012, with this indication later expanded in 2014 to include radiofrequency ablations. The research is ongoing to help accurately detect catheter movements with the help of a laser mouse-based master device. By laser sensor, the catheter’s position changes can be obtained.
Competitive Landscape
Some of The Key Players in The Remote Catheter Manipulation Device Market:
- Proven process medical devices
- Sterotaxis, Inc
- Hansen Medical
- Catheter Precision Inc
- Boston scientific
- Biosense Webster
- Other Prominent Players
Market Segmentation
The catheter manipulation devices are segmented based on indication, type of catheter, and geography. On the basis of indication the devices are further sub-segmented into electrophysiology studies, Vascular Interventional Surgery, and RF catheter ablation. The ablation process needs a special ablation catheter. Catheter ablation is the most popularly used procedure for Arrhythmias, having a high success rate. EP studies are used either to diagnose arrhythmias or to assist in cardiac ablation procedures and hence will hold a higher market share. This subsegment is expected to grow the fastest due to the increased establishment of EP labs every year in the United States.
On the basis of types of catheter, the devices are segmented into, Intracardiac Echocardiography (ICE), ablation catheter, and circular mapping catheter. The standard ICE catheter utilizes a linear array of crystals arranged longitudinally along the catheter to produce a fan-shaped image radiating coplanar to the long axis of the catheter. The ablation catheter is adjusted to the proper position by the operator, and the machine sends either RF waves, extremely cold temperatures, or laser light through it to make a scar, called an ablation line. Manipulator for circular mapping catheter is responsible for advancement, retraction, rotation, tip deflection, and loop size of the catheter. The circular mapping catheter manipulator is used to remotely control both the circular mapping catheter and the ablation catheter this leads to improved procedure outcomes, hence this is expected to gain market share over single ICE and ablation catheter manipulators.
Geographically the global market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2014 North America accounted for the largest share of the market. Europe followed North America on account of revenue. The Asia-Pacific market is expected to grow due to the increasing aging population, improving and modernizing healthcare infrastructure, and high demand for electrophysiology devices, with a special focus on countries like India, China, and Japan.
A number of factors such as the development of technologically advanced catheter manipulation devices, increasing aging population with a high risk of cardiovascular diseases, increasing incidence of arrhythmia cases across the globe, growing focus of key market players to expand their geographic presence, and growing demand of ablation procedures drives the growth of the global market.
Recent Developments:
- In April 2024, Boston Scientific Corporation started the FARAVIEWTM Software Module* NAVIGATE-PF research when it comes to tracking and visualizing the FARAWAVETM Nav Pulsed Field Ablation (PFA) Catheter* when it comes to treating patients with paroxysmal and chronic atrial fibrillation (AF). Through interaction with our cardiac mapping system, the FARAVIEW technology and the FARAWAVE Nav catheter increase the capabilities of the FARAPULSETM PFA System.
Competitive Landscape
Some of The Key Players in The Remote Catheter Manipulation Device Market:
- Proven process medical devices
- Sterotaxis, Inc
- Hansen Medical
- Catheter Precision Inc
- Boston scientific
- Biosense Webster
- Other Prominent Players
The Remote Catheter Manipulation Device Market Report Scope
Report Attribute |
Specifications |
Growth Rate CAGR |
CAGR of 6.8% from 2024 to 2031 |
Quantitative Units |
Representation of revenue in US$ Million, Volume (Unit), and CAGR from 2024 to 2031 |
Historic Year |
2019 to 2023 |
Forecast Year |
2024-2031 |
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
Segments Covered |
By Type of Catheter, By Indication, |
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
Competitive Landscape |
Proven process medical devices, Sterotaxis, Inc., Hansen Medical, Catheter Precision Inc., Boston scientific, Biosense Webster, and Others |
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |